Cargando…

Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt

BACKGROUND: Psoriasis is a complex autoimmune multifactorial disease induced by interaction of environmental and genetic factors. This research aimed to clarify the association of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) polymorphisms with susceptibility to psoriasis. METHODS: This case–c...

Descripción completa

Detalles Bibliográficos
Autores principales: ALrefai, Abeer, Dawood, Ashraf, Shehata, Wafaa, Elhelbawy, Mohammed, Elhelbawy, Nesreen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324977/
https://www.ncbi.nlm.nih.gov/pubmed/34345180
http://dx.doi.org/10.2147/TACG.S319065
_version_ 1783731475623968768
author ALrefai, Abeer
Dawood, Ashraf
Shehata, Wafaa
Elhelbawy, Mohammed
Elhelbawy, Nesreen
author_facet ALrefai, Abeer
Dawood, Ashraf
Shehata, Wafaa
Elhelbawy, Mohammed
Elhelbawy, Nesreen
author_sort ALrefai, Abeer
collection PubMed
description BACKGROUND: Psoriasis is a complex autoimmune multifactorial disease induced by interaction of environmental and genetic factors. This research aimed to clarify the association of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) polymorphisms with susceptibility to psoriasis. METHODS: This case–control study involved 150 patients diagnosed with psoriasis and 100 age- and gender-matched apparently healthy individuals. NLRP3 (rs10754558) polymorphism was done by real time PCR and PTPN22 1858C/T (rs2476601) genotype was identified by tetra-primer amplification refractory mutation system-polymerase chain reaction (PCR) method. RESULTS: The genotypes distribution of NLRP3 (rs10754558) were significantly associated with psoriasis (p<0.0001). Whereas for PTPN22 (1858C/T) (rs2476601), no significance was found (p=0.09). NLRP3 (rs10754558) GC genotype revealed a significant association with psoriasis (p<0.0001), mainly among male (p=0.004) patients with mild psoriasis (p=0.001) and affected extremities (p=0.0001). CONCLUSION: We can conclude that the NLRP3 (rs10754558) GC genotype may play a role in psoriasis susceptibility among male Egyptian populations with affected extremities. Future studies must evaluate its role in the prevention or the treatment of psoriasis.
format Online
Article
Text
id pubmed-8324977
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83249772021-08-02 Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt ALrefai, Abeer Dawood, Ashraf Shehata, Wafaa Elhelbawy, Mohammed Elhelbawy, Nesreen Appl Clin Genet Original Research BACKGROUND: Psoriasis is a complex autoimmune multifactorial disease induced by interaction of environmental and genetic factors. This research aimed to clarify the association of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) polymorphisms with susceptibility to psoriasis. METHODS: This case–control study involved 150 patients diagnosed with psoriasis and 100 age- and gender-matched apparently healthy individuals. NLRP3 (rs10754558) polymorphism was done by real time PCR and PTPN22 1858C/T (rs2476601) genotype was identified by tetra-primer amplification refractory mutation system-polymerase chain reaction (PCR) method. RESULTS: The genotypes distribution of NLRP3 (rs10754558) were significantly associated with psoriasis (p<0.0001). Whereas for PTPN22 (1858C/T) (rs2476601), no significance was found (p=0.09). NLRP3 (rs10754558) GC genotype revealed a significant association with psoriasis (p<0.0001), mainly among male (p=0.004) patients with mild psoriasis (p=0.001) and affected extremities (p=0.0001). CONCLUSION: We can conclude that the NLRP3 (rs10754558) GC genotype may play a role in psoriasis susceptibility among male Egyptian populations with affected extremities. Future studies must evaluate its role in the prevention or the treatment of psoriasis. Dove 2021-07-26 /pmc/articles/PMC8324977/ /pubmed/34345180 http://dx.doi.org/10.2147/TACG.S319065 Text en © 2021 ALrefai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
ALrefai, Abeer
Dawood, Ashraf
Shehata, Wafaa
Elhelbawy, Mohammed
Elhelbawy, Nesreen
Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title_full Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title_fullStr Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title_full_unstemmed Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title_short Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt
title_sort evaluation of nlrp3 (rs10754558) and ptpn22 (1858c/t) (rs2476601) functional polymorphisms in psoriasis susceptibility in egypt
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324977/
https://www.ncbi.nlm.nih.gov/pubmed/34345180
http://dx.doi.org/10.2147/TACG.S319065
work_keys_str_mv AT alrefaiabeer evaluationofnlrp3rs10754558andptpn221858ctrs2476601functionalpolymorphismsinpsoriasissusceptibilityinegypt
AT dawoodashraf evaluationofnlrp3rs10754558andptpn221858ctrs2476601functionalpolymorphismsinpsoriasissusceptibilityinegypt
AT shehatawafaa evaluationofnlrp3rs10754558andptpn221858ctrs2476601functionalpolymorphismsinpsoriasissusceptibilityinegypt
AT elhelbawymohammed evaluationofnlrp3rs10754558andptpn221858ctrs2476601functionalpolymorphismsinpsoriasissusceptibilityinegypt
AT elhelbawynesreen evaluationofnlrp3rs10754558andptpn221858ctrs2476601functionalpolymorphismsinpsoriasissusceptibilityinegypt